Leighann Timbs

Leighann Timbs is a Senior Director at Neurocrine Biosciences, bringing extensive experience in regulatory affairs from their previous roles at Gilead Sciences, DexCom, Inc., Phenomix Corporation, and Ascenta Therapeutics, Inc. With a background in Literature and Writing Studies, Leighann has been involved in global regulatory leadership for various drugs targeting HIV, Ebola, Marburg, and COVID. Leighann has also been a key member of regulatory teams for pediatric projects and HIV cure programs.